<div id="readability-page-1"><h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. </li><li> Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off </li></ul>GridAI Technologies ( (GRDX) ) has issued an update. On November 28, 2025, GridAI Technologies Corp. experienced significant changes in its board of directors, with the resignation of Eric Corbett due to disagreements over governance policies and Richard Paolone, who left amicably with a separation agreement. The company also completed a rebranding by changing its name from Entero Therapeutics, Inc. to GridAI Technologies Corp., effective December 1, 2025, and updated its trading symbol on Nasdaq to ‘GRDX’, reflecting its strategic shift towards AI technology. More about GridAI Technologies GridAI Technologies Corp., formerly known as Entero Therapeutics, Inc., operates in the technology industry with a focus on artificial intelligence solutions. The company recently underwent a rebranding, changing its name and trading symbol to better align with its market focus. Average Trading Volume: 216,831 Technical Sentiment Signal: Sell Current Market Cap: $7.63M Learn more about GRDX stock on TipRanks’ Stock Analysis page.</div>

ENTO

GridAI Technologies Corp. announced board changes with the resignation of Eric Corbett and Richard Paolone. The company rebranded from Entero Therapeutics, Inc. to GridAI Technologies Corp., effective December 1, 2025, and updated its Nasdaq trading symbol to 'GRDX', reflecting a strategic shift towards AI technology.

GridAI Technologies Announces Board Changes and Rebranding